Recombinant SARS-CoV-2 Spike anticorps (AA 16-685)

N° du produit ABIN6953151

L’anticorps Chimeric Chimeric anti-SARS-CoV-2 Spike a été validé pour ELISA et GICA. Il convient pour détecter SARS-CoV-2 Spike dans des échantillons de SARS Coronavirus-2 (SARS-CoV-2).

Aperçu rapide pour Recombinant SARS-CoV-2 Spike anticorps (AA 16-685) (ABIN6953151)

Antigène: SARS-CoV-2 Spike

Type d'anticorp: Recombinant Antibody

Reactivité: SARS Coronavirus-2 (SARS-CoV-2)

Hôte: Chimeric

Clonalité: Chimeric

Conjugué: Cet anticorp SARS-CoV-2 Spike est non-conjugé

Application: ELISA, Colloidal Gold Immunochromatography Assay (GICA)

Clone: H6

Détail du produit anti-SARS-CoV-2 Spike anticorps

Épitope: AA 16-685

Fonction: S Recombinant Monoclonal Antibody

Attributs du produit: Recombinant anti-SARS-CoV-2 spike is expressed from 293 cells (HEK293) ,It is a chimeric monoclonal antibody combining the mouse variable regions with the constant domains of human IgG1.
Monoclonal mouse (varialbe region) / human (kappa / IgG1 constant)chimeric antibody.
AA 16-685

Purification: Affinity-chromatography

Immunogène: Recombinant Human Novel Coronavirus Spike glycoprotein (S) (16-685aa) (CSB-MP3324GMY)

Isotype: Ig kappa, IgG1

Information d'application

Indications d'application: ELISA:1:10000-1:50000, GICA:1:500-1:25000

Restrictions: For Research Use only

Stockage

Format: Liquid

Buffer: Preservative: 0.03 % Proclin 300
Constituents: 50 % Glycerol, 0.01M PBS, PH 7.4

Agent conservateur: ProClin

Précaution d'utilisation: This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Stock: -20 °C,-80 °C

Stockage commentaire: Upon receipt, store at -20°C or -80°C. Avoid repeated freeze

Détails sur SARS-CoV-2 Spike

Antigène: SARS-CoV-2 Spike

Autre désignation: SARS-CoV-2 (SARS-CoV-2/ 2019-nCoV) S

Sujet: Spike glycoprotein comprises two functional subunits responsible for binding to the host cell receptor (S1 subunit) and fusion of the viral and cellular membranes (S2 subunit). For many coronavirus (CoVs), S is cleaved at the boundary between the S1 and S2 subunits, which remain non-covalently bound in the prefusion conformation. The distal S1 subunit comprises the receptor-binding domain(s) and contributes to stabilization of the prefusion state of the membrane-anchored S2 subunit that contains the fusion machinery. S is further cleaved by host proteases at the so-called S2' site located immediately upstream of the fusion peptide in all CoVs. This cleavage has been proposed to activate the protein for membrane fusion via extensive irreversible conformational changes. However, different CoVs use distinct domains within the S1 subunit to recognize a variety of attachment and entry receptors, depending on the viral species. Endemic human coronaviruses OC43 and HKU1 attach via their S domain A to 5-N-acetyl-9-O-acetyl-sialosides found on glycoproteins and glycolipids at the host cell surface to enable entry into susceptible cells. MERS-CoV S uses domain A to recognize non-acetylated sialoside attachment receptors, which likely promote subsequent binding of domain B to the entry receptor, dipeptidyl-peptidase 4. SARS-CoV and several SARS-related coronaviruses (SARSr-CoV) interact directly with angiotensin-converting enzyme 2 (ACE2) via SB to enter target cells.

ID gène: 43740568

UniProt: P0DTC2